Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant V Bommi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oncotarget|November 10, 2018
DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell CarcinomaPrashant V Bommi, Sriram Ravindran, Pradip Raychaudhuri, et al.
Cell Cycle (Georgetown, Tex.)|March 25, 2011
βTrCP regulates BMI1 protein turnover via ubiquitination and degradationAnagh A Sahasrabuddhe, Manjari Dimri, Prashant V Bommi, et al.
Oncogene|November 20, 2019
NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCCPrashant V Bommi, Vaibhav Chand, Nishit K Mukhopadhyay, et al.
Cell Cycle (Georgetown, Tex.)|June 15, 2010
The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitorsPrashant V Bommi, Manjari Dimri, Anagh A Sahasrabuddhe, et al.
Carcinogenesis|December 9, 2009
Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cellsManjari Dimri, Prashant V Bommi, Anagh A Sahasrabuddhe, et al.
Molecular Cancer|June 24, 2010
Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domainAjay K Yadav, Anagh A Sahasrabuddhe, Manjari Dimri, et al.
Iscience|September 26, 2022
Chemical inhibition of oxygen-sensing prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogrammingRatnakar Tiwari, Prashant V Bommi, Peng Gao, et al.
Cancer Research|April 24, 2013
DDB2 suppresses epithelial-to-mesenchymal transition in colon cancerNilotpal Roy, Prashant V Bommi, Uppoor G Bhat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 16, 2021
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous PolyposisCharles M Bowen, Lewins Walter, Ester Borras, et al.
Cell Reports|August 18, 2021
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathwayRafael Torosyan, Shengping Huang, Prashant V Bommi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncotarget|November 10, 2018
DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell CarcinomaPrashant V Bommi, Sriram Ravindran, Pradip Raychaudhuri, et al.
Cell Cycle (Georgetown, Tex.)|March 25, 2011
βTrCP regulates BMI1 protein turnover via ubiquitination and degradationAnagh A Sahasrabuddhe, Manjari Dimri, Prashant V Bommi, et al.
Oncogene|November 20, 2019
NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCCPrashant V Bommi, Vaibhav Chand, Nishit K Mukhopadhyay, et al.
Cell Cycle (Georgetown, Tex.)|June 15, 2010
The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitorsPrashant V Bommi, Manjari Dimri, Anagh A Sahasrabuddhe, et al.
Carcinogenesis|December 9, 2009
Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cellsManjari Dimri, Prashant V Bommi, Anagh A Sahasrabuddhe, et al.
Molecular Cancer|June 24, 2010
Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domainAjay K Yadav, Anagh A Sahasrabuddhe, Manjari Dimri, et al.
Iscience|September 26, 2022
Chemical inhibition of oxygen-sensing prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogrammingRatnakar Tiwari, Prashant V Bommi, Peng Gao, et al.
Cancer Research|April 24, 2013
DDB2 suppresses epithelial-to-mesenchymal transition in colon cancerNilotpal Roy, Prashant V Bommi, Uppoor G Bhat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 16, 2021
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous PolyposisCharles M Bowen, Lewins Walter, Ester Borras, et al.
Cell Reports|August 18, 2021
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathwayRafael Torosyan, Shengping Huang, Prashant V Bommi, et al.
Pageof 2